Post by
Dude51 on May 30, 2020 4:15pm
To the moon ALICE where else would this stock go
"We are highly encouraged by the results of this study, which demonstrate the potential of R-100, the active payload of R-107, to block tissue injury in an aggressive and clinically predictive model of lethal sepsis in the mouse. We plan to clinically explore its efficacy in COVID-19 pulmonary infection and acute lung injury. We are also exploring its potential in other forms of acute lung injury, such as chlorine inhalation lung injury, smoke inhalation injury and bacterial sepsis," said Robert Farrell, chief executive officer of Kalytera.
Excellent Management, thanks Robert.
Comment by
JMark80 on May 31, 2020 12:53am
Excellent mgmt? Are you new to Kaly? Robert is a cuck.
Comment by
scaley on May 31, 2020 11:05am
I like Mr. Robert. He is about to make me a lot of cash . Let him do his job. Calling names when you don't even know the guy is pathetic. Smh
Comment by
JMark80 on May 31, 2020 11:19am
You like him because you're an idiot.